Updated Jul 16, 2026
Ballal Rahul D. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.41M.
Rahul D. Ballal is a corporate executive known for his role as a director at Agios Pharmaceuticals, Inc. and Enliven Therapeutics, Inc. He has been involved in the biopharmaceutical industry, focusing on developing medicines for rare diseases.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 | |
| 2025-08-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.3K | $0.00 | |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 1.5K | $59.21 | $89K |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 4.9K | $58.57 | $289K |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 3.6K | $57.24 | $204K |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 10.0K | $25.99 | $260K |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 1.9K | $54.41 | $102K |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 8.1K | $53.32 | $434K |
| 2024-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 10.0K | $25.99 | $260K |
| 2024-10-10 | ELVN | Enliven Therapeutics, Inc. | S — Open-market sale [10b5-1] | 10.4K | $28.17 | $294K |
| 2024-10-10 | ELVN | Enliven Therapeutics, Inc. | M — Option exercise [10b5-1] | 4.1K | $5.52 | $23K |
| 2024-10-10 | ELVN | Enliven Therapeutics, Inc. | M — Option exercise [10b5-1] | 6.3K | $19.68 | $124K |
Rahul D. Ballal is a corporate executive known for his role as a director at Agios Pharmaceuticals, Inc. and Enliven Therapeutics, Inc. He has been involved in the biopharmaceutical industry, focusing on developing medicines for rare diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($1.41M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ballal Rahul D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.